Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Cardiff Oncology, Inc. | a2209502zs-1a.htm |
| EX-1.1 - EX-1.1 - Cardiff Oncology, Inc. | a2209502zex-1_1.htm |
| EX-5.1 - EX-5.1 - Cardiff Oncology, Inc. | a2209502zex-5_1.htm |
| EX-4.2 - EX-4.2 - Cardiff Oncology, Inc. | a2209502zex-4_2.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
Trovagene, Inc.
San Diego, California
We hereby consent to the use in the Prospectus constituting a part of this Amendment No. 2 to the Registration Statement of our report dated March 30, 2012, relating to the consolidated financial statements of Trovagene, Inc., which is contained in that Prospectus. Our report contains an explanatory paragraph regarding the Company's ability to continue as a going concern.
We also consent to the reference to us under the caption "Experts" in the Prospectus.
/s/
BDO USA, LLP
New York, New York
May 18, 2012
Consent of Independent Registered Public Accounting Firm